Tetrahydrofuran

Tetrahydrofuran

SCHEMBL10761380

C1CCOC1.COC(C)=O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.56
▸ GLA P06280 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ TSHR P16473 3/20 0.35
▸ PKM P14618 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ HPGD P15428 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ MGLL Q99685 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MGAM O43451 1/20 0.32
▸ GAA P10253 1/20 0.32
▸ SI P14410 1/20 0.32
▸ MGAM2 Q2M2H8 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofuran SCHEMBL29171726 0.97 ALDH1A1 (0.53) ALDH1A1GLASMN1; SMN2TSHRPKM
Tetrahydrofuran SCHEMBL29171727 0.93 ALDH1A1 (0.48) ALDH1A1GLASMN1; SMN2TSHRPKM
Dioxane SCHEMBL11028398 0.88 ALDH1A1 (0.62) ALDH1A1GLASMN1; SMN2TSHRPKM
Acetic Acid Methyl Ester SCHEMBL16927894 0.85 — —
Tetrahydrofuran SCHEMBL1938419 0.83 ALDH1A1 (0.56) ALDH1A1GLASMN1; SMN2TSHRPKM
Tetrahydrofuran SCHEMBL4337006 0.83 ALDH1A1 (0.56) ALDH1A1GLASMN1; SMN2TSHRPKM
Tetrahydrofuran SCHEMBL30284971 0.83 ALDH1A1 (0.44) ALDH1A1GLASMN1; SMN2TSHRPKM
Tetrahydrofuran SCHEMBL11884252 0.83 ALDH1A1 (0.44) ALDH1A1GLASMN1; SMN2TSHRPKM
Acetic Acid Methyl Ester SCHEMBL28148680 0.83 ALDH1A1 (0.56) ALDH1A1TSHRMGAMGAASI
Tetrahydrofuran SCHEMBL165529 0.82 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113793975-B Preparation method of fluorine-containing electrolyte 湖南法恩莱特新能源科技有限公司 2023-02-03 — — CN claimed
CN-115197075-A Preparation method of efavirenz key intermediate 盐城迪赛诺制药有限公司 2022-10-18 — — CN claimed
CN-112851623-B Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and ester thereof by using tetrahydrofurfuryl acetic acid and ester thereof 中国科学院兰州化学物理研究所 2022-04-08 — — CN claimed
CN-113968791-A Preparation method of efavirenz key intermediate 盐城迪赛诺制药有限公司 2022-01-25 — — CN claimed
CN-113793975-A Preparation method of fluorine-containing electrolyte 湖南法恩莱特新能源科技有限公司 2021-12-14 — — CN claimed
CN-112851623-A Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and ester thereof by using tetrahydrofurfuryl acetic acid and ester thereof 中国科学院兰州化学物理研究所 2021-05-28 — — CN claimed
CN-113793975-B Preparation method of fluorine-containing electrolyte 湖南法恩莱特新能源科技有限公司 2023-02-03 — — CN disclosed
CN-115197075-A Preparation method of efavirenz key intermediate 盐城迪赛诺制药有限公司 2022-10-18 — — CN disclosed
CN-112851623-B Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and ester thereof by using tetrahydrofurfuryl acetic acid and ester thereof 中国科学院兰州化学物理研究所 2022-04-08 — — CN disclosed
CN-113968791-A Preparation method of efavirenz key intermediate 盐城迪赛诺制药有限公司 2022-01-25 — — CN disclosed
CN-113793975-A Preparation method of fluorine-containing electrolyte 湖南法恩莱特新能源科技有限公司 2021-12-14 — — CN disclosed
CN-112851623-A Method for preparing epsilon-caprolactone, 6-hydroxycaproic acid and ester thereof by using tetrahydrofurfuryl acetic acid and ester thereof 中国科学院兰州化学物理研究所 2021-05-28 — — CN disclosed
CN-106336356-B Polyarylene material 罗门哈斯电子材料有限责任公司 2019-09-24 — — CN disclosed
CN-108148194-A For the aromatic resin of bottom 罗门哈斯电子材料有限责任公司 2018-06-12 — — CN disclosed
CN-105694005-B Silanization poly (arylene ether) 罗门哈斯电子材料有限责任公司 2018-03-16 — — CN disclosed
CN-107534146-A Nonaqueous electrolyte charge storage element negative pole 株式会社杰士汤浅国际 2018-01-02 — — CN disclosed
CN-105384915-B Polyarylene material 罗门哈斯电子材料有限责任公司 2017-12-12 — — CN disclosed
US-9334289-B2 Cephem compound having catechol or pseudo-catechol structure SHIONOGI & CO., LTD. (JP) 2016-05-10 — — US disclosed
US-20140088302-A1 NOVEL CEPHEM COMPOUND HAVING CATECHOL OR PSEUDO-CATECHOL STRUCTURE SHIONOGI & CO., LTD. (JP) 2014-03-27 — — US disclosed
US-4659682-A PRECIPITATION WITH ALCOHOLS, ACIDS, OR ESTERS THE HALCON SD GROUP, INC. (US) 1987-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140088302-A1 NOVEL CEPHEM COMPOUND HAVING CATECHOL OR PSEUDO-CATECHOL STRUCTURE COMT, CMBL, CEP170 ALDH1A1 908/4885GLA 128/4885SMN1; SMN2 4604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback